| Pharmacokinetic Study of IV Artesunate to Treat Children With Severe Malaria (NCT05750459) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-11-29 |
| L9LS MAb in Malian Adults (NCT05816330) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-05-25 |
| Comparative Study of Thrombocytopenia in Plasmodium Vivax and Falciparum Malaria (NCT07122232) | Rafiullah Hotak | 2023-04-01 |
| Anti-malaria MAb in Kenyan Children (NCT05400655) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-09-14 |
| Anti-malaria MAb in Malian Children (NCT05304611) | National Institute of Allergy and Infectious Diseases (NIAID) | 2022-03-18 |
| Reducing Malaria Transmission in Forest-going Mobile and Migrant Populations in Myanmar (NCT05025761) | Macfarlane Burnet Institute for Medical Research and Public Health Ltd | 2022-01-01 |
| Safety and Efficacy of CIS43LS Anti-malaria mAb in Mali (NCT04329104) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-02-15 |
| rCSP/AP10-602 [GLA-LSQ] Vaccine Trial (NCT03589794) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-12-21 |
| Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum Malaria (NCT03660839) | Sanofi | 2018-09-11 |
| Trial to Evaluate the Safety, Immunogenicity and Protective Efficacy of Three or Five Administrations of GAP3KO Sporozoites (NCT03168854) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-07-26 |
| A Systems Biology Approach to Malaria Immunity (NCT03014258) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-06-07 |
| Safety and Efficacy of Sanaria's PfSPZ-CVac in Malian Adults (NCT02996695) | National Institute of Allergy and Infectious Diseases (NIAID) | 2017-04-06 |
| PfSPZ Challenge in Healthy Malaria-Naïve Adults in the United States (NCT02773979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-09-12 |
| PfSPZ Challenge in Non-immune Adults in Baltimore, USA (NCT02780154) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-08-25 |
| Safety and Immunogenicity of Sanaria's Irradiated Sporozoite Vaccine (PfSPZ Vaccine) in Malaria-Experienced Adults in Burkina Faso (NCT02663700) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-04-07 |
| To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria (NCT02497612) | Sanofi | 2015-07-25 |
| Efficacy and Safety of Dihydroartemisinin-piperaquine (DHP) for the Treatment of Uncomplicated Malaria (NCT02353494) | Menzies School of Health Research | 2015-03-01 |
| Optimising Operational Use of Artemether-lumefantrine Comparing 3 Day Versus 5 Day (NCT02020330) | University of Oxford | 2013-11-25 |
| Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum Malaria (NCT00988507) | Sanofi | 2009-10-01 |
| Effect of Liver and Blood-stage Treatment on Subsequent Plasmodium Reinfection and Morbidity (NCT02143934) | Papua New Guinea Institute of Medical Research | 2009-08-01 |
| Malaria Challenge With NF54 Strain (NCT00744133) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-03-01 |
| Chloroquine Alone or in Combination for Malaria in Children in Malawi (NCT00379821) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-02-01 |
| Adenovirus Vaccine for Malaria (NCT00371189) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-01-01 |